Tradestie Institutional Equity Comparison Engine

AMGN vs REGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMGN Overall Edge

AMGN Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amgen Inc (AMGN) driven by superior Growth & Margin, Momentum & Technical while REGN counters with relative strength in Valuation, Options & Structure. Fundamentally, AMGN trades at 17.5x Forward P/E with 34.1% operating margin (+8.5% YoY revenue) versus REGN at 14.9x Forward P/E and 30.4% operating margin (+36.3% YoY). In options structure, AMGN sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against REGN sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner REGN
AMGN 17.5x vs REGN 14.9x Fwd P/E
Growth & Margin Winner AMGN
Op Margin 34.1% vs 30.4% ยท YoY +8.5% vs +36.3%
Momentum & Technical Winner AMGN
1Y +27.6% vs +27.3% ยท 52W Pos 74% vs 83%
Options & Structure Winner REGN
CONSOLIDATION (6th %ile IV) vs CONSOLIDATION (6th %ile IV)
AMGN NASDAQ
Amgen Inc
Biological Products, (No Disgnostic Substances)
$438.82
-1.14% 1D
Market Cap $240.1B
1M Return +0.11%
1Y Return +27.57%
Forward P/E 17.5x
Unified AI Score
48.4 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 68.0 Mom 46.0
REGN NASDAQ
Regeneron Pharmaceuticals Inc
Pharmaceutical Preparations
$923.34
-2.35% 1D
Market Cap $97.8B
1M Return +14.61%
1Y Return +27.3%
Forward P/E 14.9x
Unified AI Score
45.1 / 100 HOLD
Tech 28.0 Fund 45.0 Flow 68.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AMGN +27.57% REGN +27.3% Spread: +0.27 pp (AMGN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AMGN Revenue REGN Revenue AMGN Op. Margin REGN Op. Margin Margin Edge
FY2018 $23.8B $5.15B 43.2% 49.3% REGN
FY2019 $23.4B $6.56B 41.4% 33.7% AMGN
FY2020 $25.4B $8.50B 35.9% 42.1% REGN
FY2021 $26.0B $16.1B 29.4% 55.7% REGN
FY2022 $26.3B $12.2B 36.3% 38.9% REGN
FY2023 $28.2B $13.1B 28.0% 30.9% REGN
FY2024 $33.4B $14.2B 21.7% 28.1% REGN
FY2025 $36.8B $14.3B 24.7% 24.9% REGN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AMGN (5) vs REGN (5)
Institutional Metric AMGN REGN Criterion Row Winner
Market Capitalization Scale $240.1B $97.8B Larger Scale AMGN
Trailing P/E Ratio Valuation 25.7x 20.9x Lower Multiple REGN
Forward P/E Ratio Valuation 17.5x 14.9x Lower Multiple REGN
Revenue Growth (YoY) Growth +8.5% +36.3% Higher Growth REGN
Operating Margin (TTM) Profitability 34.1% 30.4% Higher Margin AMGN
Net Profit Margin Profitability 24.1% 28.5% Higher Margin REGN
Return on Equity (ROE) Capital Efficiency 78.3% 14.9% Higher ROE AMGN
52-Week Range Position Momentum 74% ($312โ€“$484) 83% ($592โ€“$992) Stronger Trend REGN
Beta / 30D Volatility Risk Regime 0.47ฮฒ ยท 26% Vol 0.32ฮฒ ยท 55% Vol Lower Realized Risk AMGN
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite AMGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AMGN vs REGN Buy Guide
AMGN CONSOLIDATION
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live AMGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
REGN CONSOLIDATION
55d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live REGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AMGN nor REGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.